Stock Entry Point Article​

Pfizer Inc – Top Pharmaceutical Company Stocks

Pfizer Inc – Top Pharmaceutical Company Stocks

Pfizer is, perhaps, one of the most well-known pharmaceutical companies in the world. It has been in the news for the past couple of years as it is one of the main vaccine providers in the US and across many other countries. It has also had its fair share of controversies due to its conditions on governments for providing its vaccines. Regardless of which side you are on when it comes to judging Pfizer, there is no doubt about the commercial might of Pfizer. Any investor looking to buy pharmaceutical stocks will almost certainly look at Pfizer before making a decision. The company is likely to be part of shortlists created by investors for pharmaceutical businesses. Besides vaccines, Pfizer has a range of products and a strong reputation for research and development.

Additional Information About Pfizer

Pfizer is ranked highly on the Fortune 500 list. Its financial strength allows it to conduct R&D on blockbuster drugs while its industry-leading salesforce offers the company the channels to distribute its innovative products. Pfizer has a basket of patent-protected drugs and generates close to $50 billion annual sales. International sales account for roughly half the total sales, while the US market makes up the other half. The company has benefitted lately from the growing demand and purchasing power in emerging markets. Pfizer was founded in 1849 by Charles Pfizer and Charles Erhart. The two were cousins who had migrated from Germany to the US in 1848. They started a chemical compound business by the name of Pfizer. The company was located in the New York neighborhood of Brooklyn. Today, it is one of the top pharmaceutical company stocks that investors can look at.

Buy Pharmaceutical Stocks

Pfizer’s stock is up 34% over 12 months. This trend is recorded as of 1st December 2021 when the stock price was $54.68. The dividend yield on the stock at the time was 2.85%. The 52-week high price was not far at $55.7, indicating that the stock has been on an uptrend lately.


Share on facebook
Share on twitter
Share on linkedin

More Posts

Send Us A Message